What are the other companies coming to market to compete against davinci? I heard from an intuitive rep that they are more concern about a German and Korean company. They feel those companies will beat Titan to the market.
Whats the deal with Titan Medical
- Thread starter Anonymous
- Start date
-
- Tags
- None
1200? I think you need to do a little research on that one, your number is way way way off!!
What you heard is wrong, there is NO WAY for procedures to be reported inaccurately by the reps.......it is all done through a network connection from the daVinci!!!!
NOW it is. This is only recent that cases are reported through an online system. You know it's true, so stop getting your panties in a bunch.
Titan is a long term play. They are going to take some share from ISRG, of course. When someone has 100% of the marketshare, it can only move in one direction. TITXF is a volatile stock. Put in a market order at 1.25 or so, and you'll have some in a few months when Europe's recapitalization plan collapses. Then put in a limit order when it hits 2.00. Not rocket science, really. Just good investing.
I hear the ISI patents are expiring, should be great fun watching this group compete.
Anyone with a link to find out when the ISI patents are expiring?
I ran across this new Medical Devices report today. It might be of interest - I found it at http://www.fastmr.com/prod/274632_masimo_corporation_market_share_analysis.aspx.
Let me know your thoughts.
Let me know your thoughts.
Titan is a true up-and-comer. They have had the opportunity to examine the best and worst ISRG has to offer and has taken steps to improve at all levels. This will be leapfrog technology for sure. Intuitive can tweak their platform here and there but will always be limited by their basic platform and having to work around the FDA. Titan will be better out of the block. Catch this stock now as clinical testing is underway.
hmmmm... let's see.. if you bought $345 dollars worth of Titan Stock one year ago (@ $1.20 per share), you could of gotten 288 shares. Today, it's worth $480 but one share of ISI stock is worth today, $539. I am not an ISI employee but I am an invester. As an invester, I take ISI over Titan anyday. Why you ask? Titan has to work around existing ISI patents and if Titan wants to sale in US then they have to work around the FDA as well. I don't see any advantage but I do see huge advantage for ISI. Why you ask? Nothing speak louder then CASH! and ISI have lots of them. Lastly, who says ISI is standing still. With all the cash in hand, It won't surpise me they are working on the next gen system. But everyone has an opinion. Of course, mine is better than yours.
hmmmm... let's see.. if you bought $345 dollars worth of Titan Stock one year ago (@ $1.20 per share), you could of gotten 288 shares. Today, it's worth $480 but one share of ISI stock is worth today, $539. I am not an ISI employee but I am an invester. As an invester, I take ISI over Titan anyday. Why you ask? Titan has to work around existing ISI patents and if Titan wants to sale in US then they have to work around the FDA as well. I don't see any advantage but I do see huge advantage for ISI. Why you ask? Nothing speak louder then CASH! and ISI have lots of them. Lastly, who says ISI is standing still. With all the cash in hand, It won't surpise me they are working on the next gen system. But everyone has an opinion. Of course, mine is better than yours.
LIKE!!
hmmmm... let's see.. if you bought $345 dollars worth of Titan Stock one year ago (@ $1.20 per share), you could of gotten 288 shares. Today, it's worth $480 but one share of ISI stock is worth today, $539. I am not an ISI employee but I am an invester. As an invester, I take ISI over Titan anyday. Why you ask? Titan has to work around existing ISI patents and if Titan wants to sale in US then they have to work around the FDA as well. I don't see any advantage but I do see huge advantage for ISI. Why you ask? Nothing speak louder then CASH! and ISI have lots of them. Lastly, who says ISI is standing still. With all the cash in hand, It won't surpise me they are working on the next gen system. But everyone has an opinion. Of course, mine is better than yours.
Actually, if you were any type of INVESTOR, you would have jumped on Titan about two years ago when it was around 20 cents a share instead of $1.20, buy a bunch at 20 cents (I bought about $35,000) and then jumped when it was at $2.00 a share.
But then again, your opinion is better than mine but I'm making more money than you.
I do you one better. If You were any type of investor, you would of bought ISI stock two years ago when it was at $84 dollars a share. I can play this game and win all day. Shall we keep going? I don't think so! See! My opinion is still better then yours!
You're opinion may be better, but your spelling and grammar are embarrassing.
I love it! This dude rips on the spelling and grammar in the other guys post, and meanwhile he uses "You're, instead of "your". What an idiot. Btw, Titan wasn't yet available for US purchase at $.20/share, so I call BS.
Yes Titan was available for US purchase for $.20 a share, maybe not on US market, but TSX could be purchased. I bought in 2009 and saw it go as low as $.05, but bought at $.2
ZZZZZZZZZZZZZZZZZZZZZZZZ.....
Really, who gives a sh$t?
That's the joy of this board. It's anonymous so people can make sh$t up all day and no one can prove if it is right or wrong.
Lt. Dan bought me some stock in Apple Computers when it just started and it is worth millions. I also a fleet of shrimp boats called Jennie and a shrimp company called Bubba Gump Shrimp.
So how easy that was to do?
Oops! I meant, "See how easy that was to do?"
I don't want the grammar police to come after me.
One issue with Titan or other companies relying on healthcare capital investment by hospitals:
Healthcare spending is 17.3% of GDP and rising and will bankrupt the US in the next 50 years if spending is not changed...
Thus, there is huge pressure to reshape the landscape of healthcare as an industry, and CMS is introducing accountable care organizations and other cost containing (value-focused) initiatives.
This reform is driving budget reductions across the health systems of America.
The result of all this reform: health systems will need to be more frugal with capital and won't be as quick to invest in new technologies because it is the "vogue" service or requested by the surgeon. Initiatives that deliver significant benefit to outcomes or experience will be the focus, and i am not convinced Titan has enough differential to merit sinking cost into a whole new robotic surgical system.
Interested in the stock but also concerned about their prospects in a challenging and cash-strapped industry.
Healthcare spending is 17.3% of GDP and rising and will bankrupt the US in the next 50 years if spending is not changed...
Thus, there is huge pressure to reshape the landscape of healthcare as an industry, and CMS is introducing accountable care organizations and other cost containing (value-focused) initiatives.
This reform is driving budget reductions across the health systems of America.
The result of all this reform: health systems will need to be more frugal with capital and won't be as quick to invest in new technologies because it is the "vogue" service or requested by the surgeon. Initiatives that deliver significant benefit to outcomes or experience will be the focus, and i am not convinced Titan has enough differential to merit sinking cost into a whole new robotic surgical system.
Interested in the stock but also concerned about their prospects in a challenging and cash-strapped industry.